comparemela.com

Page 5 - Michael Bodner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Johnson & Johnson to acquire Abiomed for $16 6B (updated)

Johnson & Johnson entered into a definitive agreement to acquire medical technology company Abiomed for approximately $16.6 billion.

Johnson medtechMichael bodnerJoaquin duatoAshley mcevoyMichael minogueCenters for diseaseJp morgan securitiesDrug administrationSullivan cromwellGoldman sachs coSwaine mooreNew brunswick headquarteredDisease controlWorldwide chairman ashley mcevoy

Johnson & Johnson to Acquire Abiomed

Transaction to bring lifesaving innovations to more patients with unmet need

Johnson medtechMichael bodnerJoaquin duatoAshley mcevoyMichaelr minogueBiosense websterChief executive officerExecutive vice presidentWorldwide chairmanChief executiveMerger subChief commercial officerInterventional cardiovascularAbbott vascularWorldwide presidentBiosense webster electrophysiology

J&J to buy heart device maker Abiomed for $16 6B

BioPharma

United statesMichael bodnerJoaquin duatoAshley mcevoyMarie thibaultRick wiseMichael minogueBoston scientificDive briefChairman michael minogueChief commercial officer andrew greenfieldBiosense webster electrophysiology

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.

United statesBruxelles capitaleJohnson medtechMila pereraGian battista chierchiaTillman dahmeMichael bodnerBoris schmidtBiosense websterCardioangiology center bethanienBiosense webster incUlm university medical centerDepartment of medicine ii cardiologyBiosense webster inc octFrom biosense webster inc octBalloon ablation catheter

Biosense Webster Launches HELIOSTAR in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution

United statesBruxelles capitaleJohnson medtechGian battista chierchiaTillman dahmeMichael bodnerBiosense websterEuropean heart rhythm associationBiosense webster incJohnson medtech companiesInstitute for health metricsEuropean association for cardioUlm university medical centerEuropean society of cardiologyGlobal burden of disease collaborative networkOrals anesthetic management in electrophysiology laboratory

vimarsana © 2020. All Rights Reserved.